In the RoP Briefing for the week of April 13:

Field Trip Psychedelics launches drug discovery division

A new study finds long lasting effects of psilocybin

Champignon Brands to acquire Altmed Capital Corp

MAPS partially halts clinical trials amid Covid-19

Calls for psychedelic approval to treat Covid-19 side effects